September 24 - September 25, 2024
SAS Institute 100 SAS Campus Drive, Cary
2024 CEO Roundtable on Cancer Annual Meeting Advancing Cancer Research and Care through Collaborative Innovation. The CEO Roundtable on Cancer Annual Meeting was held on September 24-25, 2024, at the SAS Institute in Cary, North Carolina, and featured thought-provoking keynotes, panel discussions, and presentations from luminaries in cancer research, treatment, prevention, and data science. [more]
2024 CEO Roundtable on Cancer Annual Meeting Advancing Cancer Research and Care through Collaborative Innovation. The CEO Roundtable on Cancer Annual Meeting was held on September 24-25, 2024, at the SAS Institute in Cary, North Carolina, and featured thought-provoking keynotes, panel discussions, and presentations from luminaries in cancer research, treatment, prevention, and data science. [more]
February 29 - March 1, 2024
2024 Partnership SummitSAS Institute 100 SAS Campus Drive, Cary
The 2024 Partnership Summit featured panels discussing how we are reimagining oncology clinical trials with our members and partners. [more] |
|
November 1 - November 2, 2022
After two years of virtual events, the 2022 CEO Roundtable on Cancer Annual Meeting and Conference was held Nov. 1-2 on the campus of SAS Institute in Cary, NC. CEOs and other leaders gathered to discuss the state of cancer research, policy and advocacy, recruitment and retention, benefits, and wellness. [more]
November 17, 2021
ACCELERATE HEALTH was the focus of the CEO Roundtable on Cancer’s Annual Conference on November 17, 2021. Reflecting upon the theme, the event was broadcast from the Ingram Collection of memorable Porsche sportscars with our host, Founding CEO Roundtable on Cancer Chairman Robert A. Ingram, past CEO of Glaxo Wellcome, General Partner of Hatteras Venture Partners, cancer survivor, inspirational leader, and Porsche aficionado extraordinaire. [more]
September 23, 2021
Executive Summary Overview: For the last 6 years, the CEO Roundtable on Cancer’s Project Data Sphere (PDS) has actively partnered with the FDA through a series of symposia focused on building consensus within the scientific community in support of advanced cancer research. [more]
March 30, 2021
Project Data Sphere's Teilo Schaller hosted the irAE symposium to share the progress and discuss future directions for the irAE field. [more]
October 7, 2020
Executive Summary PDS Symposium IX on rare cancer registries was a virtual meeting held on Oct. 7, 2020. For the first time in our annual symposia series, we met online and addressed critical questions in the field of rare cancer registries, with an ultimate goal to drive improvements in patient treatment, bringing safe and effective drugs to patients with rare malignancies in the most efficient and expeditious manner. [more]
November 11, 2019
FDA-PDS Symposium VIII: Artificial Intelligence in Tumor Imaging: Needs, Opportunities & Challenges Executive Summary Goals and Objectives In 2014 the CEO Roundtable on Cancer's Project Data Sphere® (PDS), in partnership with the FDA, founded a series of symposia devoted to areas fertile for fresh attention in the realm of cancer clinical trials. [more]
April 17, 2019
FDA-PDS Symposium VII: Immune-Related Adverse Events and Checkpoint Blockade Combination Therapies. The keynote addressed Current Clinical Challenges in Immune-Related Adverse Events and Emerging Opportunities: The MGH Experience delivered by Kerry Reynolds, MD, Director of the Severe Immunotherapy Complications Service and Clinical Director, Massachusetts General Hospital. [more]
August 8, 2018
Symposium VI: Small Cell Lung Cancer (SCLC) External Control Arm: A Paradigm Shift in Cancer Drug Evaluation/Registration. This meeting was recapped in the Executive Summary. [more]
October 24, 2017
On October 24, 2017, near US Food and Drug Administration headquarters in Bethesda, MD, we co-hosted our fifth FDA-PDS Symposium on “Growing Dimensions of Big Data in Cancer Research.” Propelled by recent collaborative progress such as the New England Journal of Medicine (NEJM) Project Data Sphere-inspired “Sounding Board” article, “Advantages of a Truly Open-Access Data-Sharing Model” and the issuance of a Letter of Support from Dr. Pazdur, Director of the Oncology Center of Excellence, participants were provided updates and data sharing innovations from the FDA’s Oncology Center of Excellence, the Project Data Sphere initiative, and highlight other advances and opportunities in oncology treatment, research and development and regulatory science. [more]
May 2, 2017
FDA-PDS Symposium IV: Project Data Sphere, LLC & NCTN Data Archive Initiative fostered landmark collaboration among leaders in oncology treatment, research and development, and regulatory science, and join rich knowledge, diverse expertise, impressive experience, and unwavering commitment to the mission of curing cancer and improving care for patients. [more]
November 29, 2016
FDA-PDS Symposium III: Intermediate Endpoints in Immuno-Oncology convened for the purpose of converting the ideas into actions -- not for us, not for our companies -- but for patients. [more]
May 3, 2016
FDA-PDS Symposium II: From Silos to Solutions meeting convened on May 3, 2016 [more]
November 30, 2015
FDA-PDS Symposium I: Prostate Cancer DREAM Challenge contemplated the future of medical evidence generation. [more]
